In the last trading session, 0.14 million GeneDx Holdings Corp (NASDAQ:WGS) shares changed hands as the company’s beta touched 2.10. With the company’s per share price at $77.40 changed hands at $1.0 or 1.31% during last session, the market valuation stood at $2.09B. WGS’s last price was a discount, traded about -15.13% off its 52-week high of $89.11. The share price had its 52-week low at $2.47, which suggests the last value was 96.81% up since then. When we look at GeneDx Holdings Corp’s average trading volume, we note the 10-day average is 0.52 million shares, with the 3-month average coming to 629.35K.
Analysts gave the GeneDx Holdings Corp (WGS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WGS as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. GeneDx Holdings Corp’s EPS for the current quarter is expected to be 0.11.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Instantly WGS was in green as seen at the end of in last trading. With action -4.04%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 2663.64%, with the 5-day performance at -4.04% in the red. However, in the 30-day time frame, GeneDx Holdings Corp (NASDAQ:WGS) is -3.44% down. Looking at the short shares, we see there were 2.28 million shares sold at short interest cover period of 3.02 days.
The consensus price target for the stock as assigned by Wall Street analysts is 45, meaning bulls need a downside of -72.0% from its current market value. According to analyst projections, WGS’s forecast low is 34 with 70 as the target high. To hit the forecast high, the stock’s price needs a 9.56% surge from its current level, while the stock would need to tank 56.07% for it to hit the projected low.
GeneDx Holdings Corp (WGS) estimates and forecasts
Data shows that the GeneDx Holdings Corp share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 190.19% over the past 6 months, a 95.38% in annual growth rate that is considerably higher than the industry average of 6.80%. Year-over-year growth is forecast to reach 42.27% up from the last financial year.
Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of 80.22M. 6 analysts are of the opinion that GeneDx Holdings Corp’s revenue for the current quarter will be 77.8M. The company’s revenue for the corresponding quarters a year ago was 57.42M and 62.42M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 39.72%. The estimates for the next quarter sales put growth at 24.63%.
The 2024 estimates are for GeneDx Holdings Corp earnings to increase by 93.74%.
WGS Dividends
GeneDx Holdings Corp is expected to release its next quarterly earnings report in January.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 18.19% of GeneDx Holdings Corp shares while 72.00% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 88.00%. There are 72.00% institutions holding the GeneDx Holdings Corp stock share, with CASDIN CAPITAL, LLC the top institutional holder. As of 2024-06-30, the company held 13.2482% of the shares, roughly 3.53 million WGS shares worth $92.18 million.
CORVEX MANAGEMENT LP holds the second largest percentage of outstanding shares, with 9.2937% or 2.47 million shares worth $64.66 million as of 2024-06-30.
